Annual Net Income
$18.25 M
+$75.71 M+131.75%
December 31, 2024
Summary
- As of March 14, 2025, CSTL annual net profit is $18.25 million, with the most recent change of +$75.71 million (+131.75%) on December 31, 2024.
- During the last 3 years, CSTL annual net income has risen by +$49.54 million (+158.31%).
- CSTL annual net income is now at all-time high.
Performance
CSTL Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
$9.59 M
+$7.32 M+322.65%
December 31, 2024
Summary
- As of March 14, 2025, CSTL quarterly net profit is $9.59 million, with the most recent change of +$7.32 million (+322.65%) on December 31, 2024.
- Over the past year, CSTL quarterly net income has increased by +$12.17 million (+471.71%).
- CSTL quarterly net income is now at all-time high.
Performance
CSTL Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
$18.25 M
+$12.17 M+200.33%
December 31, 2024
Summary
- As of March 14, 2025, CSTL TTM net profit is $18.25 million, with the most recent change of +$12.17 million (+200.33%) on December 31, 2024.
- Over the past year, CSTL TTM net income has increased by +$75.71 million (+131.75%).
- CSTL TTM net income is now at all-time high.
Performance
CSTL TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
CSTL Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +131.8% | +471.7% | +131.8% |
| 3 y3 years | +158.3% | +471.7% | +131.8% |
| 5 y5 years | +245.8% | +471.7% | +131.8% |
CSTL Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +127.2% | at high | +132.8% | at high | +120.5% |
| 5 y | 5-year | at high | +127.2% | at high | +132.8% | at high | +120.5% |
| alltime | all time | at high | +127.2% | at high | +132.8% | at high | +120.5% |
Castle Biosciences Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $18.25 M(-131.7%) | $9.59 M(+322.7%) | $18.25 M(+200.3%) |
| Sep 2024 | - | $2.27 M(-74.6%) | $6.08 M(-296.0%) |
| Jun 2024 | - | $8.92 M(-452.0%) | -$3.10 M(-89.9%) |
| Mar 2024 | - | -$2.53 M(-1.8%) | -$30.80 M(-46.4%) |
| Dec 2023 | -$57.47 M(-14.4%) | -$2.58 M(-62.6%) | -$57.47 M(-23.9%) |
| Sep 2023 | - | -$6.91 M(-63.2%) | -$75.50 M(-15.0%) |
| Jun 2023 | - | -$18.78 M(-35.7%) | -$88.85 M(+23.9%) |
| Mar 2023 | - | -$29.20 M(+41.6%) | -$71.72 M(+6.8%) |
| Dec 2022 | -$67.14 M(+114.6%) | -$20.62 M(+1.8%) | -$67.14 M(+26.8%) |
| Sep 2022 | - | -$20.25 M(+1128.7%) | -$52.95 M(+19.0%) |
| Jun 2022 | - | -$1.65 M(-93.3%) | -$44.49 M(-13.8%) |
| Mar 2022 | - | -$24.62 M(+282.9%) | -$51.63 M(+65.0%) |
| Dec 2021 | -$31.29 M | -$6.43 M(-45.5%) | -$31.29 M(+5.2%) |
| Sep 2021 | - | -$11.79 M(+34.1%) | -$29.75 M(+31.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$8.79 M(+105.4%) | -$22.55 M(+49.0%) |
| Mar 2021 | - | -$4.28 M(-12.5%) | -$15.13 M(+47.2%) |
| Dec 2020 | -$10.28 M(-294.9%) | -$4.89 M(+6.5%) | -$10.28 M(+207.9%) |
| Sep 2020 | - | -$4.59 M(+233.5%) | -$3.34 M(-147.1%) |
| Jun 2020 | - | -$1.38 M(-341.4%) | $7.10 M(-1.5%) |
| Mar 2020 | - | $570.00 K(-72.3%) | $7.21 M(+36.5%) |
| Dec 2019 | $5.28 M(-182.9%) | $2.06 M(-64.9%) | $5.28 M(-25.6%) |
| Sep 2019 | - | $5.85 M(-560.9%) | $7.09 M(-421.0%) |
| Jun 2019 | - | -$1.27 M(-6.6%) | -$2.21 M(-46.1%) |
| Mar 2019 | - | -$1.36 M(-135.1%) | -$4.09 M(-35.7%) |
| Dec 2018 | -$6.37 M(-48.5%) | $3.87 M(-212.1%) | -$6.37 M(-37.8%) |
| Sep 2018 | - | -$3.45 M(+9.4%) | -$10.24 M(+50.8%) |
| Jun 2018 | - | -$3.15 M(-13.1%) | -$6.79 M(+86.9%) |
| Mar 2018 | - | -$3.63 M | -$3.63 M |
| Dec 2017 | -$12.37 M | - | - |
FAQ
- What is Castle Biosciences annual net profit?
- What is the all time high annual net income for Castle Biosciences?
- What is Castle Biosciences annual net income year-on-year change?
- What is Castle Biosciences quarterly net profit?
- What is the all time high quarterly net income for Castle Biosciences?
- What is Castle Biosciences quarterly net income year-on-year change?
- What is Castle Biosciences TTM net profit?
- What is the all time high TTM net income for Castle Biosciences?
- What is Castle Biosciences TTM net income year-on-year change?
What is Castle Biosciences annual net profit?
The current annual net income of CSTL is $18.25 M
What is the all time high annual net income for Castle Biosciences?
Castle Biosciences all-time high annual net profit is $18.25 M
What is Castle Biosciences annual net income year-on-year change?
Over the past year, CSTL annual net profit has changed by +$75.71 M (+131.75%)
What is Castle Biosciences quarterly net profit?
The current quarterly net income of CSTL is $9.59 M
What is the all time high quarterly net income for Castle Biosciences?
Castle Biosciences all-time high quarterly net profit is $9.59 M
What is Castle Biosciences quarterly net income year-on-year change?
Over the past year, CSTL quarterly net profit has changed by +$12.17 M (+471.71%)
What is Castle Biosciences TTM net profit?
The current TTM net income of CSTL is $18.25 M
What is the all time high TTM net income for Castle Biosciences?
Castle Biosciences all-time high TTM net profit is $18.25 M
What is Castle Biosciences TTM net income year-on-year change?
Over the past year, CSTL TTM net profit has changed by +$75.71 M (+131.75%)